Company Encyclopedia
View More
name
CareRay
688607.SH
CareRay Digital Medical Technology Co., Ltd. engages in research and development, production, and sales of digital X-ray flat panel detectors in China. The company offers Gen3 panels; radiography products, including wireless, tethered, and specialized panels, as well as accessories; mammography, fluoroscopy, dental, and industrial NDT products; and custom panels. It also provides solutions for retrofit and OEMS; precision low dose care; dynamic DR; and customized solutions.
900.37 B
688607.SHMarket value -Rank by Market Cap -/-

Financial Score

20/11/2025 Update
B
Health Care EquipmentIndustry
Industry Ranking26/63
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE0.63%D
    • Profit Margin1.65%C
    • Gross Margin36.38%C
  • Growth ScoreC
    • Revenue YoY14.17%B
    • Net Profit YoY-78.08%E
    • Total Assets YoY4.17%C
    • Net Assets YoY0.54%C
  • Cash ScoreA
    • Cash Flow Margin6069.33%A
    • OCF YoY14.17%B
  • Operating ScoreD
    • Turnover0.34D
  • Debt ScoreA
    • Gearing Ratio13.17%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    CareRay: Inquiry for transfer pricing at RMB 22.99 per share

    CareRay announced that based on the inquiry subscription situation on October 28, 2025, the preliminary transfer price is set at 22.99 yuan per share. A total of 12 institutional investors participated in the bidding, including fund management companies and qualified foreign institutional investors, with a total effective subscription of 6.002 million shares and an effective subscription multiple of 1.28 times. The shares for this transfer have been fully subscribed, with the transferees being 11 institutional investors, intending to acquire a total of 4.7 million shares

    Zhitong·
    SH
    688607
    -2.17%
    Zhitong·
    SH
    688607
    -2.17%

    CareRay: Shareholder inquires about transferring 5.33% of the company's shares

    CareRay announced that Suzhou Kangcheng Enterprise Management Consulting Service Co., Ltd. and Ningbo Meishan Bonded Port Area Tongchi Investment Management Partnership plan to transfer 5.33% of the company's shares, totaling 4.7 million shares. This transfer will not be conducted through centralized bidding or block trading, and the transferee must have corresponding pricing capability and risk tolerance. The lower limit of the transfer price is 70% of the average price of the 20 trading days prior to the subscription invitation. The transferee may not transfer the shares within 6 months after the acquisition

    Zhitong·
    SH
    688607
    -2.17%
    Zhitong·
    SH
    688607
    -2.17%

    CareRay released its performance for the first three quarters, with a net profit attributable to the parent company of 348,000 yuan, a decrease of 97.24%

    According to the Zhitong Finance APP, CareRay released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 226 million yuan, a year-on-year increase of 15.61%. The net profit attributable to shareholders of the listed company was 348,000 yuan, a year-on-year decrease of 97.24%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 4.3482 million yuan. The basic earnings per share were 0 yuan

    Zhitong·
    SH
    688607
    -2.17%
    Zhitong·
    SH
    688607
    -2.17%

    CareRay: Plans to invest 20 million yuan to acquire a 6.67% stake in Renyan Information

    On the evening of August 15th, CareRay announced that in order to promote the company's strategic transformation and upgrade, create a second growth curve for its business operations, and focus on AI-enabled grassroots healthcare, the company plans to use 20 million yuan to increase its capital and acquire shares in Shanghai Renyan Information Technology Co., Ltd. After the capital increase is completed, the company will hold 6.67% equity in Renyan Information

    Zhitong·
    SH
    688607
    -2.17%
    Zhitong·
    SH
    688607
    -2.17%

    CareRay released its first-quarter performance, reporting a net loss attributable to the parent of 3.2813 million yuan, turning from profit to loss

    According to the Zhitong Finance APP, CareRay released its first-quarter report for 2025, with the company's first-quarter operating revenue of 58.439 million yuan, a year-on-year increase of 10.33%; the net loss attributable to shareholders of the listed company was 3.2813 million yuan, turning from profit to loss; the net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 4.6881 million yuan, with losses widening; the basic loss per share was 0.04 yuan/share

    Zhitong·
    SH
    688607
    -2.17%
    Zhitong·
    SH
    688607
    -2.17%